Comparison of Dasatinib- and Imatinib-Related Cardiotoxic Adverse Events in Japanese Patients With Chronic Myeloid Leukemia and Gastrointestinal Stromal Tumor

Background: Despite the beneficial effects of BCR-ABL1 tyrosine kinase inhibitors (TKIs) in the treatment of chronic myeloid leukemia (CML), they may also cause adverse events (AEs), especially cardiovascular toxicity. The incidence of TKI-induced AEs may vary among ethnic groups, and there is littl...

Descripción completa

Detalles Bibliográficos
Autores principales: Motokawa, Tetsufumi, Ikeda, Satoshi, Ueno, Yuki, Eguchi, Masamichi, Minami, Takako, Kawano, Hiroaki, Kobayashi, Kazuma, Imaizumi, Yoshitaka, Maemura, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2021
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710638/
https://www.ncbi.nlm.nih.gov/pubmed/35083382
http://dx.doi.org/10.1253/circrep.CR-21-0140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710638/
https://www.ncbi.nlm.nih.gov/pubmed/35083382
http://dx.doi.org/10.1253/circrep.CR-21-0140

Ejemplares similares